By uniting a cross-disciplinary hub of people and teams in a collaborative, not-for-profit model, the PROOF Centre can speed up development of new blood tests to address organ failure and disease.
The PROOF Centre has biomarker programs to develop simple blood tests for transplant patients and patients with chronic organ disease. Current programs focus on heart failure, COPD, and chronic kidney disease.
The PROOF Centre’s service arm provides expertise in computation, “-omic” science and biomarker workflow to organizations seeking to discover, develop and implement blood-based molecular biomarkers in a clinical setting.
2015 Quon B, Dai DLY, Hollander Z, Ng RT, Tebbutt S, Wilcox S, Sin DD. Discovery Of Novel Plasma Protein Biomarkers To Predict Imminent Cystic Fibrosis Pulmonary Exacerbations Using Multiple Reaction Monitoring Mass Spectrometry. Thorax. 2015 Mar 16. doi: 10.1136/thoraxjnl-2014-206710....Read more